T1	tradename 110 115	Ontak
T2	tradename 177 190	Ontak. ONTAK"
T3	nanoparticle 193 213	denileukin diftitox)
T4	routeofadministration 228 239	intravenous
T5	fdaapprovaldate 272 276	1999
T6	adversereaction 286 337	SERIOUS INFUSION REACTIONS, CAPILLARY LEAK SYNDROME
T7	adversereaction 342 364	LOSS OF VISUAL ACUITY.
T8	adversereaction 479 516	Serious and fatal infusion reactions.
T9	tradename 528 533	Ontak
T10	adversereaction 612 635	Capillary leak syndrome
T11	adversereaction 664 703	Loss of visual acuity and color vision.
T12	tradename 812 812	
T13	indication 887 1007	persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor.
T14	co-administereddrug 1081 1094	antihistamine
T15	co-administereddrug 1099 1112	acetaminophen
T16	tradename 1127 1132	Ontak
T17	dose 1157 1170	9 or 18 mcg/g
T18	frequency 1170 1174	/day
T19	routeofadministration 1178 1189	intravenous
T20	duration 1225 1243	5 consecutive days
T21	frequency 1244 1257	every 21 days
T22	adversereaction 1509 1528	Infusion reactions:
T23	tradename 1574 1579	Ontak
T24	adversereaction 1584 1611	serious infusion reactions.
T25	adversereaction 1657 1681	Capillary leak syndrome:
T26	adversereaction 1754 1793	Loss of Visual Acuity and Color Vision:
T27	tradename 1963 1968	Ontak
T28	adversereaction 2122 2146	pyrexia, nausea,fatigue,
T29	adversereaction 2148 2216	igors, vomiting, diarrhea, headache, peripheral edema,cough, dyspnea
T30	adversereaction 2221 2229	prurtus.
T31	company 2281 2291	Eisai Inc.
T32	adversereaction 2725 2776	SERIOUS INFUSION REACTIONS, CAPILLARY LEAK SYNDROME
T33	adversereaction 2781 2803	LOSS OF VISUAL ACUITY.
T34	adversereaction 3010 3028	Infusion Reactions
T35	adversereaction 3033 3056	Capillary Leak Syndrome
T36	adversereaction 3061 3072	Visual Loss
T37	tradename 3791 3796	Ontak
T38	indication 3846 3965	peristent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor
T39	co-administereddrug 4094 4107	antihistamine
T40	co-administereddrug 4112 4125	acetaminophen
T41	tradename 4141 4146	Ontak
T42	dose 4173 4185	9 or 18 mcgl
T43	frequency 4185 4189	/day
T44	routeofadministration 4193 4204	intravenous
T45	duration 4238 4256	5 consecutive days
T46	frequency 4257 4270	every 21 days
T47	tradename 4354 4359	Ontak
T48	tradename 4623 4628	Ontak
T49	tradename 5064 5069	Ontak
T50	tradename 5110 5115	Ontak
T51	tradename 5219 5224	Ontak
T52	tradename 5508 5514	Ontak.
T53	tradename 5529 5534	Ontak
T54	tradename 5573 5578	Ontak
T55	tradename 5642 5647	Ontak
T56	tradename 5733 5738	Ontak
T57	adversereaction 5915 5954	Infusion Reactions Infusion reactions,
T58	tradename 6113 6126	Ontak-treated
T59	adversereaction 6205 6231	Serious infusion reactions
T60	tradename 6266 6279	Ontak-treated
T61	tradename 6417 6422	Ontak
T62	tradename 6587 6593	Ontak.
T63	tradename 6645 6650	Ontak
T64	tradename 6712 6717	Ontak
T65	adversereaction 6722 6749	serious infusion reactions.
T66	adversereaction 6756 6804	Capillary Leak Syndrome Capillary leak syndrome
T67	adversereaction 6880 6923	hypotension; edema, serum album -c3.0 g/dL)
T68	tradename 6943 6948	Ontak
T69	adversereaction 7038 7062	capillary leak syndrome.
T70	adversereaction 7075 7099	capillary leak syndrome
T71	tradename 7134 7147	Ontak-treated
T72	adversereaction 7187 7211	capillary leak syndrome,
T73	adversereaction 7341 7365	capillary leak syndrome
T74	adversereaction 7426 7450	capillary leak syndrome
T75	tradename 7565 7571	Ontak.
T76	adversereaction 7639 7657	edema, hypotension
T77	tradename 7822 7827	Ontak
T78	adversereaction 7919 7954	Visual Loss Loss of visual acuity,
T79	adversereaction 7968 7989	loss of color vision,
T80	adversereaction 8007 8031	retinal pigment mottling
T81	tradename 8076 8082	Ontak.
T82	adversereaction 8182 8200	visual impairment.
T83	tradename 8328 8334	Ontak:
T84	tradename 8625 8630	Ontak
T85	adversereaction 8873 8891	Infusion Reactions
T86	adversereaction 8929 8952	Capillary Leak Syndrome
T87	tradename 9370 9375	Ontak
T88	dose 9379 9386	9 mcg/g
T89	dose 9397 9404	18mcg/g
T90	tradename 9517 9530	Ontak-treated
T91	dose 9571 9585	9 and 18 mcg/g
T92	dose 9646 9654	18 mcg/g
T93	tradename 9947 9953	Ontak,
T94	adversereaction 9980 10076	pyrexia, nausea, fatigue, rigors; vomiting, diarrhea, headache, peripheral edema, cough, dyspnea
T95	adversereaction 10081 10090	pruritus.
T96	adversereaction 10138 10161	capillary leak syndrome
T97	adversereaction 10170 10188	infusion reactions
T98	adversereaction 10226 10247	loss of visual acuity
T99	tradename 10254 10259	Ontak
T100	tradename 10383 10388	Ontak
T101	tradename 10547 10552	Ontak
T102	dose 10587 10594	9 mcg/g
T103	dose 10630 10638	18 mcg/g
T104	tradename 10859 10872	Ontak-treated
T105	dose 10883 10891	18 mcg/g
T106	tradename 10947 10958	Ontak Ontak
T107	dose 10972 10986	9mcg/g 18mcg/g
T108	adversereaction 11051 11057	Pyrxia
T109	adversereaction 11087 11093	Nausea
T110	adversereaction 11124 11130	Rigors
T111	adversereaction 11160 11167	Fatigue
T112	adversereaction 11198 11207	Vomitting
T113	adversereaction 11234 11242	Headache
T114	adversereaction 11273 11288	Edema perpheral
T115	adversereaction 11319 11327	Diarrhea
T116	adversereaction 11355 11363	Anorexia
T117	adversereaction 11390 11394	Rash
T118	adversereaction 11423 11430	Myalgia
T119	adversereaction 11460 11465	Cough
T120	adversereaction 11492 11500	Pruritus
T121	adversereaction 11530 11539	Back pain
T122	adversereaction 11569 11577	Asthenia
T123	adversereaction 11606 11617	Hypotension
T124	adversereaction 11644 11677	Upper respiratory tract infection
T125	adversereaction 11703 11711	Diziness
T126	adversereaction 11739 11749	Arthralgia
T127	adversereaction 11777 11781	Pain
T128	adversereaction 11808 11818	Chest pain
T129	adversereaction 11845 11854	Dysgeusia
T130	adversereaction 11878 11885	Dyspnea
T131	adversereaction 11939 12026	Increase in serum alanine aminotransferase (ALT) or aspartate aminotransferase (AST)
T132	tradename 12083 12088	Ontak
T133	tradename 12300 12306	Ontak.
T134	nanoparticle 12351 12370	denileukin diftitox
T135	nanoparticle 12488 12507	denileukin diftitox
T136	nanoparticle 12784 12803	denileukin difttox,
T137	nanoparticle 13047 13067	denileukin diftitox.
T138	nanoparticle 13403 13422	denileukin diftitox
T139	nanoparticle 13564 13584	denileukin diftitox,
T140	activeingredient 13669 13685	diphtheria toxin
T141	nanoparticle 13831 13840	 diftitox
T142	dose 13884 13898	9 and 18 mcg/g
T143	frequency 13898 13902	/day
T144	auc 14021 14025	80%)
T145	tradename 14654 14660	Ontak.
T146	adversereaction 14882 14927	hyperthyroidism, thyroiditis, thyrotoxicosis,
T147	adversereaction 14932 14947	hypothyroidism.
T148	tradename 15037 15043	Ontak.
T149	tradename 15278 15290	Ontak. Ontak
T150	tradename 15396 15401	Ontak
T151	tradename 15560 15566	Ontak,
T152	tradename 15643 15649	Ontak,
T153	tradename 15846 15851	Ontak
T154	dose 16055 16064	31 mcg/kg
T155	frequency 16064 16069	/day)
T156	adversereaction 16101 16132	nausea, vomiting, fever, chills
T157	adversereaction 16140 16160	persistent asthenia.
T158	tradename 16179 16184	Ontak
T159	nanoparticle 16186 16206	denileukin diftitox)
T160	activeingredient 16296 16312	diphtheria toxin
T161	molecularweight 16489 16495	58 kD.
T162	tradename 16583 16588	Ontak
T163	routeofadministration 16664 16680	intravenous (IV)
T164	tradename 16716 16721	Ontak
T165	nanoparticle 16754 16773	denileukin diftitox
T166	inactiveingredient 16799 16810	citric acid
T167	inactiveingredient 16820 16824	EDTA
T168	inactiveingredient 16839 16853	polysorbate 20
T169	inactiveingredient 16866 16871	Water
T170	nanoparticle 16989 17008	Denileukin diftitox
T171	activeingredient 17072 17088	diphtheria toxin
T172	nanoparticle 17215 17234	denileukin diftitox
T173	activeingredient 17340 17356	diphtheria toxin
T174	nanoparticle 17561 17580	denileukin diftitox
T175	dose 17620 17631	3 to 31 mcg
T176	frequency 17631 17636	/day)
T177	indication 17654 17663	lymphoma.
T178	nanoparticle 17666 17685	Denileukin diftitox
T179	routeofadministration 17709 17711	IV
T180	nanoparticle 17801 17820	denileukin diftitox
T181	eliminationhalflife 17968 17985	70 to 80 minutes)
T182	clearance 18077 18095	0.6 to 2.0 mL/ming
T183	volumeofdistribution 18174 18192	0.06 to 0.09 L/kg)
T184	nanoparticle 18456 18476	denileukin diftitox.
T185	nanoparticle 18629 18669	denileukin diftitox. Denileukin diftitox
T186	nanoparticle 18813 18832	denileukin diftitox
T187	tradename 18972 18977	Ontak
T188	dose 19308 19325	0, 9 or 18 mcg/kg
T189	frequency 19325 19329	/day
T190	tradename 19330 19335	Ontak
T191	routeofadministration 19340 19351	intravenous
T192	duration 19378 19383	21day
T193	dose 19769 19775	9mcg/g
T194	frequency 19775 19779	/day
T195	tradename 19780 19786	Ontak.
T196	dose 19805 19813	18 mcg/g
T197	frequency 19813 19817	/day
T198	tradename 19818 19824	Ontak.
T199	dose 20891 20905	9 or l8 mcg/kg
T200	frequency 20905 20909	/day
T201	tradename 21247 21252	Ontak
T202	routeofadministration 21276 21278	iv
T203	frequency 21288 21293	daily
T204	duration 21298 21304	5 days
T205	frequency 21305 21319	every 3 weeks.
T206	tradename 21363 21368	Ontak
T207	tradename 21755 21760	Ontak
T208	dose 22220 22227	9 mcg/g
T209	frequency 22227 22231	/day
T210	dose 22232 22240	18 mcg/g
T211	frequency 22240 22244	/day
T212	tradename 22535 22540	Ontak
T213	adversereaction 22789 22849	Fever, chills, breathing problems, chest pain, tachycardia,
T214	adversereaction 22854 22861	uricara
T215	adversereaction 22886 22911	Rapid weight gain, edema,
T216	adversereaction 22916 22939	orthostatic hypotension
T217	adversereaction 23007 23051	Visual loss, including loss of color vision.
T218	company 23087 23097	Eisai Inc.
